Pamela Oconnor
Family Medicine · The Woodlands, TXNPI 1265413256
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,152 and has fallen 95.3% since, to $54 in 2024.
Across 254 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$469
- GSK$424
- AstraZeneca$351
- Novo Nordisk$283
- Kowa Pharmaceuticals America, Inc.$203
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,53199%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 74 | $1,065 |
| Lilly USA, LLC | 31 | $469 |
| GSK | 19 | $424 |
| AstraZeneca | 21 | $351 |
| Novo Nordisk | 18 | $283 |
| Kowa Pharmaceuticals America, Inc. | 10 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $179 |
| Pfizer | 8 | $144 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $142 |
| Mylan Specialty L.p. | 4 | $124 |
| Bausch Health US, LLC | 7 | $122 |
| Vertiflex, Inc. | 1 | $120 |
| Boehringer Ingelheim | 6 | $120 |
| Bayer | 3 | $83 |
| Biohaven Pharmaceuticals, Inc. | 4 | $78 |
| Abbott | 4 | $71 |
| Eisai Inc. | 4 | $69 |
| Boston Scientific | 3 | $64 |
| Esperion Therapeutics, Inc. | 3 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Amarin Pharma, Inc. | 3 | $53 |
| Merck | 2 | $38 |
| Cleerly, Inc. | 1 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Novartis | 1 | $23 |
| Exact Sciences | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Amgen | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Ascend Therapeutics US, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
- Superion ISS$120
- NURTEC ODT$120
- ANORO$114
How this compares
$4,561 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $231 |
| Fluconazole | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other family medicine in The Woodlands
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.